Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

751246

registered interest
date	12/07/2017
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Land: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, whether he has plans to reinstate the contaminated land capital grants programme.
tabling member constituency	Mid Derbyshire
tabling member printed	Pauline Latham
uin	4701
answer	answer is ministerial correction date of answer 17/07/2017 answer text <p>There are no plans to reinstate the contaminated land capital grants programme.</p><p> </p> answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey question first answered 17/07/2017 16:46:13 answering member 4098 label Biography information for Dr Thérèse Coffey
tabling member	4025 label Biography information for Mrs Pauline Latham

751368

registered interest
date	12/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what funding is available for treatments which have been made available under the Early Access to Medicines Scheme after marketing authorisation but before the publication of NICE guidance.
tabling member constituency	Mid Derbyshire
tabling member printed	Pauline Latham
uin	4699
answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Early Access to Medicines Schemes is a voluntary scheme. Companies are not paid for the medicines they supply into the scheme. However, the Government has recently announced new funding as part of a of a wider package of up to £86 million aimed at addressing barriers to uptake of innovation that were recommended in the Accelerated Access Review. Small to Medium Enterprises with products that meet the requirements for the Early Access to Medicines Scheme will be able to access this funding opportunity. Further announcements will be made on how small businesses can apply for this support. More information can be found at this link:</p><p> </p><p><a href="https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology" target="_blank">https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 4700 question first answered 20/07/2017 15:14:36 answering member 4067 label Biography information for Steve Brine
tabling member	4025 label Biography information for Mrs Pauline Latham

751369

registered interest
date	12/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to transfer the funding of medicines under the Early Access to Medicines Scheme from pharmaceutical companies to the NHS.
tabling member constituency	Mid Derbyshire
tabling member printed	Pauline Latham
uin	4700
answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Early Access to Medicines Schemes is a voluntary scheme. Companies are not paid for the medicines they supply into the scheme. However, the Government has recently announced new funding as part of a of a wider package of up to £86 million aimed at addressing barriers to uptake of innovation that were recommended in the Accelerated Access Review. Small to Medium Enterprises with products that meet the requirements for the Early Access to Medicines Scheme will be able to access this funding opportunity. Further announcements will be made on how small businesses can apply for this support. More information can be found at this link:</p><p> </p><p><a href="https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology" target="_blank">https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 4699 question first answered 20/07/2017 15:14:36 answering member 4067 label Biography information for Steve Brine
tabling member	4025 label Biography information for Mrs Pauline Latham